Vinorelbine alternating oral and intravenous plus epirubicin in first-line therapy of metastatic breast cancer: results of a multicentre phase II study

Podobne zapisy

• Oral vinorelbine versus intravenous vinorelbine, in combination with epirubicin as first-line chemotherapy in Chinese patients with metastatic breast cancer
  od: Huang, Liang, i wsp.
  Wydane: (2019)
• Phase II multicentre randomised study of docetaxel plus epirubicin vs 5-fluorouracil plus epirubicin and cyclophosphamide in metastatic breast cancer
  od: Bonneterre, J, i wsp.
  Wydane: (2004)
• Multicentric phase II trial of gemcitabine plus epirubicin plus paclitaxel as first-line chemotherapy in metastatic breast cancer
  od: Cappuzzo, F, i wsp.
  Wydane: (2004)
• Weekly epirubicin plus docetaxel as first-line treatment in metastatic breast cancer
  od: Gamucci, T, i wsp.
  Wydane: (2007)
• A randomised, multicentre open-label phase II study to evaluate the efficacy, tolerability and pharmacokinetics of oral vinorelbine plus cisplatin versus intravenous vinorelbine plus cisplatin in Chinese patients with chemotherapy-naive unresectable or metastatic non-small cell lung cancer
  od: Yang, Yunpeng, i wsp.
  Wydane: (2019)